Managing acute oncology: Toxicities, complications and challenges

Learn about treatment toxicity management and complications of advanced cancer

Oncology treatment options have expanded exponentially with the introduction of complex multi-drug regimens, immunotherapies and advanced targeted therapies. Toxicities from these therapies are challenging for clinical staff who care for oncology patients. Improved patient treatment options result in improved survival outcomes, necessitating more personalised approaches to cancer complications.

This study day will focus on developing an understanding of the approach to assessment of the acutely unwell oncology patient including management of therapy toxicities and complications of advanced cancer.

Friday 26 September 2025, 9am to 5pm BST - The Christie Institute for Cancer Education, Education Centre

What to expect

Initial assessment of the acutely unwell oncology patient
Prognosis for metastatic cancer patients in the modern oncology era
Management of immunotherapy toxicities
Management of complex SACT toxicity
Emergency endocrine presentations
Common complications of metastatic cancer e.g. bowel obstruction, upper GI bleed
Ambulatory management approaches of toxicity and complications

Managing acute oncology study day - Friday 26 September 2025

Time	Session
08:45	Registration
09:15	Welcome to the day Chair of the day: Dr Jamie Weaver, Locum Consultant, The Christie NHS Foundation Trust
09:20	Cancer prognosis in the era of modern SACT and its influence on decision making for the acutely unwell oncology patient Dr Jamie Weaver, Locum Consultant, The Christie NHS Foundation Trust
09:55	Recognising the acutely deteriorating oncology patient TBC

10:30 - break

Time	Session
10:50	Acute oncology presentations in breast cancer patients Dr Caroline Wilson, Acute Oncologist and Breast Consultant Medical Oncologist, The Christie NHS Foundation Trust
11:25	Endocrine emergencies in acute oncology, immunotherapy toxicity and beyond TBC
12:00	Acute management of life-threatening ICI-toxicities TBC

12:35 - lunch

Time	Session
13:30	ICI-toxicity guidelines st The Christie Dr Jamie Weaver, Locum Consultant, The Christie NHS Foundation Trust
14:05	Acute management of toxicity related to novel antibody drug conjugates TBC

14:40 - break

Time	Session
15:00	Ambulatory management of the acute oncology patient TBC
15:35	Case-based discussion with acute oncology panel TBC

16:00 - conclusion and close of day

Platinum sponsors

Bronze sponsors

Education events sponsorship opportunities

If you are interested in sponsorship opportunities, see how you can support the development of cancer education and patient care.